Related references
Note: Only part of the references are listed.Diversity within the adenovirus fiber knob hypervariable loops influences primary receptor interactions
Alexander T. Baker et al.
NATURE COMMUNICATIONS (2019)
CryoEM structure of adenovirus type 3 fibre with desmoglein 2 shows an unusual mode of receptor engagement
Emilie Vassal-Stermann et al.
NATURE COMMUNICATIONS (2019)
Human adenovirus type 26 uses sialic acid-bearing glycans as a primary cell entry receptor
Alexander T. Baker et al.
SCIENCE ADVANCES (2019)
Innate immunity to adenovirus: lessons from mice
Svetlana Atasheva et al.
FEBS LETTERS (2019)
Improvements to the APBS biomolecular solvation software suite
Elizabeth Jurrus et al.
PROTEIN SCIENCE (2018)
The Novel Oncolytic Adenoviral Mutant Ad5-3Δ-A20T Retargeted to αvβ6 Integrins Efficiently Eliminates Pancreatic Cancer Cells
Y. K. Stella Man et al.
MOLECULAR CANCER THERAPEUTICS (2018)
Mapping of Adenovirus of serotype 3 fibre interaction to desmoglein 2 revealed a novel 'non-classical' mechanism of viral receptor engagement
Emilie Vassal-Stermann et al.
SCIENTIFIC REPORTS (2018)
Seroprevalence of Neutralizing Antibodies against Human Adenovirus Type-5 and Chimpanzee Adenovirus Type-68 in Cancer Patients
Hua Zhao et al.
FRONTIERS IN IMMUNOLOGY (2018)
Designer Oncolytic Adenovirus: Coming of Age
Alexander T. Baker et al.
CANCERS (2018)
Oncolytic Group B Adenovirus Enadenotucirev Mediates Non-apoptotic Cell Death with Membrane Disruption and Release of Inflammatory Mediators
Arthur Dyer et al.
MOLECULAR THERAPY-ONCOLYTICS (2017)
Immunostimulatory AdCD40L gene therapy combined with low-dose cyclophosphamide in metastatic melanoma patients
Angelica Loskog et al.
BRITISH JOURNAL OF CANCER (2016)
Efficient Transduction of Primary Vascular Cells by the Rare Adenovirus Serotype 49 Vector
Rachel S. Dakin et al.
HUMAN GENE THERAPY (2015)
The EMBL-EBI bioinformatics web and programmatic tools framework
Weizhong Li et al.
NUCLEIC ACIDS RESEARCH (2015)
Activity of a group B oncolytic adenovirus (ColoAd1) in whole human blood
Y. Di et al.
GENE THERAPY (2014)
Survivin promoter-regulated oncolytic adenovirus with Hsp70 gene exerts effective antitumor efficacy in gastric cancer immunotherapy
Weiguo Wang et al.
ONCOTARGET (2014)
Low Seroprevalent Species D Adenovirus Vectors as Influenza Vaccines
Eric A. Weaver et al.
PLOS ONE (2013)
Coagulation factor X mediates adenovirus type 5 liver gene transfer in non-human primates (Microcebus murinus)
R. Alba et al.
GENE THERAPY (2012)
Sequencing and phylogenetic analysis of the hexon, fiber, and penton regions of adenoviruses isolated from AIDS patients
Yasir Mohammed A. Al Qurashi et al.
JOURNAL OF MEDICAL VIROLOGY (2012)
Avidity Binding of Human Adenovirus Serotypes 3 and 7 to the Membrane Cofactor CD46 Triggers Infection
Hung V. Trinh et al.
JOURNAL OF VIROLOGY (2012)
Vaccination with Adenovirus Serotypes 35, 26, and 48 Elicits Higher Levels of Innate Cytokine Responses than Adenovirus Serotype 5 in Rhesus Monkeys
Jeffrey E. Teigler et al.
JOURNAL OF VIROLOGY (2012)
Adenoviral Vector Immunity: Its Implications and Circumvention Strategies
Yadvinder S. Ahi et al.
CURRENT GENE THERAPY (2011)
Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega
Fabian Sievers et al.
MOLECULAR SYSTEMS BIOLOGY (2011)
Combination with low-dose gemcitabine and hTERT-promoter-dependent conditionally replicative adenovirus enhances cytotoxicity through their crosstalk mechanisms in pancreatic cancer
Manabu Onimaru et al.
CANCER LETTERS (2010)
Identification of coagulation factor (F)X binding sites on the adenovirus serotype 5 hexon: effect of mutagenesis on FX interactions and gene transfer
Raul Alba et al.
BLOOD (2009)
Adenoviruses: update on structure and function
W. C. Russell
JOURNAL OF GENERAL VIROLOGY (2009)
Re-engineering adenovirus vector systems to enable high-throughput analyses of gene function
Richard J. Stanton et al.
BIOTECHNIQUES (2008)
Adenovirus serotype 5 hexon mediates liver gene transfer
Simon N. Waddington et al.
CELL (2008)
Novel human adenovirus causing nosocomial epidemic keratoconjunctivitis
Hiroaki Ishiko et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2008)
Comparative seroprevalence and immunogenicity of six rare serotype recombinant adenovirus vaccine vectors from subgroups B and D
Peter Abbink et al.
JOURNAL OF VIROLOGY (2007)
Multiple vitamin K-dependent coagulation zymogens promote adenovirus-mediated gene delivery to hepatocytes
Alan L. Parker et al.
BLOOD (2006)
Generation of a novel replication-incompetent adenoviral vector derived from human adenovirus type 49: manufacture on PER.C6 cells, tropism and immunogenicity
Angelique A. C. Lemckert et al.
JOURNAL OF GENERAL VIROLOGY (2006)
The influence of adenovirus fiber structure and function on vector development for gene therapy
SA Nicklin et al.
MOLECULAR THERAPY (2005)
Crystal structure of species D adenovirus fiber knobs and their sialic acid binding sites
WP Burmeister et al.
JOURNAL OF VIROLOGY (2004)
CD46 is a cellular receptor for group B adenoviruses
A Gaggar et al.
NATURE MEDICINE (2003)
In vivo hepatic adenoviral gene delivery occurs independently of the coxsackievirus-adenovirus receptor
T Smith et al.
MOLECULAR THERAPY (2002)
Adenovirus type 5 viral particles pseudotyped with mutagenized fiber proteins show diminished infectivity of coxsackie B-adenovirus receptor-bearing cells
JL Jakubczak et al.
JOURNAL OF VIROLOGY (2001)
Dependence of adenovirus infectivity on length of the fiber shaft domain
DM Shayakhmetov et al.
JOURNAL OF VIROLOGY (2000)
Adenovirus type 37 uses sialic acid as a cellular receptor
N Arnberg et al.
JOURNAL OF VIROLOGY (2000)
Share Paper
